TB
ABBV icon

Terril Brothers’s AbbVie ABBV Stock Holding History

Terril Brothers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Hold
1,082
– – 0.07% 59
2026
Q1 		$235K Buy
1,082
+102
+10% +$22.6K 0.06% 70
2025
Q4 		$224K Hold
980
– – 0.06% 68
2025
Q3 		$227K Buy
+980
New +$200K 0.07% 72
2025
Q1 		– Sell
-1,148
Closed -$204K – 59
2024
Q4 		$204K Buy
1,148
+3
+0.3% +$552 0.06% 68
2024
Q3 		$226K Buy
+1,145
New +$214K 0.07% 53

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Terril Brothers's ABBV Position: Q2 2026 in Review

Terril Brothers held its AbbVie (ABBV) position steady in Q2 2026 at 1,082 shares worth $272K. The position accounts for 0.07% of the portfolio, ranked #59.

Terril Brothers first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Terril Brothers held 1,082 shares of AbbVie worth $272K as of Q2 2026.
  • Terril Brothers left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.07% of Terril Brothers's portfolio in Q2 2026, its #59 holding.
  • Terril Brothers first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Terril Brothers's 13F filing for Q2 2026, filed 24 Jul 2026.